BRAFV600E overrides NOTCH signaling in thyroid cancer. Traversi F, Stooss A, Dettmer MS, Charles RP, et al. Thyroid 2020 Oct 3. doi: 10.1089/thy.2019.0595.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Traversi F, Stooss A, Dettmer MS, Charles RP, et al. BRAFV600E overrides NOTCH signaling in thyroid cancer. Thyroid 2020 Oct 3. doi: 10.1089/thy.2019.0595.
PMID: 33012268